Anziva Pharmaceuticals develops differentiated drug delivery products using known therapeutic agents and practical regulatory pathways.
Our lead program, J’Neura™, is a knee-specific non-opioid pain patch designed to address a clear gap in the topical pain market: products made specifically for the knee joint.
We are interested in speaking with companies focused on:
Potential structures include licensing, co-development, regional commercialization, global commercialization, or strategic acquisition.